Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Dapat, Isolde C ^a   Dapat, Clyde ^a   Baranovich, Tatiana ^a,c   Suzuki, Yasushi ^a,d   Kondo, Hiroki ^a   Shobugawa, Yugo ^a   Saito, Reiko ^a   Suzuki, Hiroshi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA SEIRYO UNIVERSITY   (Japan)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANTIVIRAL RESISTANCE; ARTICLE; FLU LIKE SYNDROME; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEMAGGLUTININ GENE; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; JAPAN; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; NEURAMINIDASE GENE; NONHUMAN; PANDEMIC; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SEASONAL VARIATION; SPECIES DOMINANCE; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN; VIRUS TYPING;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA, HUMAN; JAPAN; MOLECULAR SEQUENCE DATA; MUTATION; ORTHOMYXOVIRIDAE; PANDEMICS; PHYLOGENY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SEASONS;

CERCOPITHECINE HERPESVIRUS 1; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 84863008174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036455     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention (CDC) (2009) Outbreak of swine-origin influenza A (H1N1) virus infection- Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 58: 467-470.
2. Centers for Disease Control and Prevention (CDC) (2009) Update: swine influenza A (H1N1) infections-California and Texas, April 2009. MMWR Morb Mortal Wkly Rep 58: 435-437.
3. World Health Organization (WHO) (2009) New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 84: 249-257.
4. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
5. Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, et al. (2010) Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antivir Ther 15: 1151-1159.
6. World Health Organization (WHO) (2009) Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly Epidemiol Rec 84: 453-459.
7. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O, (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 15: 155-162.
8. Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, et al. (2010) Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J Clin Virol 47: 23-28.
9. Shimada T, Gu Y, Kamiya H, Komiya N, Odaira F, et al. (2009) Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009. Euro Surveill 14.
10. Infectious Disease Surveillance Center (IDSC) (2009) Pandemic (H1N1) 2009 in Japan, May-September 2009. Available: http://idsc.nih.go.jp/iasr/30/356/tpc356.html. Accessed 2011 Sep 21.
11. Shiino T, Okabe N, Yasui Y, Sunagawa T, Ujike M, et al. (2010) Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One 5: e11057.
12. Morlighem J, Aoki S, Kishima M, Hanami M, Ogawa C, et al. (2011) Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. PLoS One 6: e18956.
13. Fereidouni SR, Beer M, Vahlenkamp T, Starick E, (2009) Differentiation of two distinct clusters among currently circulating influenza A(H1N1)v viruses, March-September 2009. Euro Surveill 14.
14. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360.
15. Ikonen N, Haanpää M, Rönkkö E, Lyytikäinen O, Kuusi M, et al. (2010) Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLoS One 5: e13329.
16. Kilander A, Rykkvin R, Dudman SG, Hungnes O, (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15.
17. Fanning TG, Reid AH, Taubenberger JK, (2000) Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions. Virology 276: 417-423.
18. Wiley DC, Wilson IA, Skehel JJ, (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
19. Gulati U, Hwang CC, Venkatramani L, Gulati S, Stray SJ, et al. (2002) Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J Virol 76: 12274-12280.
20. Berton MT, Naeve CW, Webster RG, (1984) Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies. J Virol 52: 919-927.
21. Infectious Disease Surveillance Center (IDSC) (2010) 2009/10 influenza season, Japan. Available: http://idsc.nih.go.jp/iasr/31/367/tpc367.html. Accessed 2011 Sep 21.
22. Toyokawa T, Sunagawa T, Yahata Y, Ohyama T, Kodama T, et al. (2011) Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe, Japan. J Infect 63: 281-287.
23. Iwatsuki-Horimoto K, Horimoto T, Tamura D, Kiso M, Kawakami E, et al. (2011) Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan. Clin Vaccine Immunol 18: 860-866.
24. Chen H, Cheung CL, Tai H, Zhao P, Chan JF, et al. (2009) Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 15: 1970-1972.
25. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, et al. (2010) A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 362: 86-87.
26. Ujike M, Ejima M, Anraku A, Shimabukuro K, Obuchi M, et al. (2011) Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis 17: 470-479.
27. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
28. Centers for Disease Control and Prevention (CDC) (2010) Update: influenza activity- United States, 2009-10 season. MMWR Morb Mortal Wkly Rep 59: 901-908.
29. National Institute for Medical Research (NIMR) (2011) February 2011 interim report. Available: http://www.nimr.mrc.ac.uk/who-influenza-centre/annual-and-interim-reports/. Accessed 2011 Sep 21.
30. Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, et al. (2011) Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill 16.
31. Zaraket H, Saito R, Suzuki Y, Caperig-Dapat I, Dapat C, et al. (2010) Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2. Antivir Ther 15: 307-319.
32. Dapat C, Suzuki Y, Kon M, Tamura T, Saito R, et al. (2011) Phylogenetic analysis of an off-seasonal influenza virus A (H3N2) in Niigata, Japan, 2010. Jpn J Infect Dis 64: 237-241.
33. World Health Organization (WHO) (2010) Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec 85: 81-92.
34. Barr I, Komadina N, Hurt A, Shaw R, Durrant C, et al. (2003) Reassortants in recent human influenza A and B isolates from South East Asia and Oceania. Virus Res 98: 35-44.
35. World Health Organization (WHO) (2011) Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Wkly Epidemiol Rec 86: 86-90.
36. Kilbourne ED, (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12: 9-14.
37. Dapat C, Saito R, Kyaw Y, Naito M, Hasegawa G, et al. (2009) Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007. Intervirology 52: 310-320.
38. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
39. Suzuki Y, Saito R, Zaraket H, Dapat C, Caperig-Dapat I, et al. (2010) Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method. J Clin Microbiol 48: 57-63.
40. Suzuki Y, Saito R, Sato I, Zaraket H, Nishikawa M, et al. (2011) Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method. J Clin Microbiol 49: 125-130.
41. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
42. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
43. Tamura K, Nei M, Kumar S, (2004) Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 101: 11030-11035.
44. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242.
45. Vijaykrishna D, Poon LL, Zhu HC, Ma SK, Li OT, et al. (2010) Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 328: 1529.